| The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications JM Loftis, A Janowsky Pharmacology & therapeutics 97 (1), 55-85, 2003 | 507 | 2003 |
| Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan EH Turner, JM Loftis, AD Blackwell Pharmacology & therapeutics 109 (3), 325-338, 2006 | 319 | 2006 |
| Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies JM Loftis, M Huckans, BJ Morasco Neurobiology of disease 37 (3), 519-533, 2010 | 300 | 2010 |
| The phenomenology and treatment of interferon-induced depression JM Loftis, P Hauser Journal of affective disorders 82 (2), 175-190, 2004 | 267 | 2004 |
| Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia HA Mansour, ME Talkowski, J Wood, KV Chowdari, L McClain, K Prasad, ... Bipolar disorders 11 (7), 701-710, 2009 | 172 | 2009 |
| Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1β and tumor necrosis factor-α JM Loftis, M Huckans, S Ruimy, DJ Hinrichs, P Hauser Neuroscience letters 430 (3), 264-268, 2008 | 139 | 2008 |
| A randomized trial of paroxetine to prevent interferon-α-induced depression in patients with hepatitis C BJ Morasco, MA Rifai, JM Loftis, DW Indest, JK Moles, P Hauser Journal of affective disorders 103 (1-3), 83-90, 2007 | 134 | 2007 |
| Methamphetamine causes persistent immune dysregulation: a cross-species, translational report JM Loftis, D Choi, W Hoffman, MS Huckans Neurotoxicity research 20 (1), 59-68, 2011 | 120 | 2011 |
| Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care DL Sylvestre, JM Loftis, P Hauser, S Genser, H Cesari, N Borek, ... Journal of Urban Health 81 (4), 719-734, 2004 | 113 | 2004 |
| Psychiatric and substance use disorders in individuals with hepatitis C JM Loftis, AM Matthews, P Hauser Drugs 66 (2), 155-174, 2006 | 105 | 2006 |
| Neuroimmune basis of methamphetamine toxicity JM Loftis, A Janowsky International review of neurobiology 118, 165-197, 2014 | 93 | 2014 |
| Association of interferon-α-induced depression and improved treatment response in patients with hepatitis C JM Loftis, RE Socherman, CD Howell, AJ Whitehead, JA Hill, JA Dominitz, ... Neuroscience letters 365 (2), 87-91, 2004 | 92 | 2004 |
| Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies M Kohno, J Link, LE Dennis, H McCready, M Huckans, WF Hoffman, ... Pharmacology Biochemistry and Behavior 179, 34-42, 2019 | 77 | 2019 |
| Prairie voles as a novel model of socially facilitated excessive drinking AMJ Anacker, JM Loftis, S Kaur, AE Ryabinin Addiction biology 16 (1), 92-107, 2011 | 72 | 2011 |
| Protected environment for cancer patients: effect of a prophylactic antibiotic regimen on the microbial flora of patients undergoing cancer chemotherapy GP Bodey, J Loftis, E Bowen Archives of Internal Medicine 122 (1), 23-30, 1968 | 70 | 1968 |
| Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial BJ Morasco, JM Loftis, DW Indest, S Ruimy, JW Davison, B Felker, ... Psychosomatics 51 (5), 401-408, 2010 | 67 | 2010 |
| Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal JM Loftis, A Janowsky Journal of neurochemistry 75 (5), 2040-2050, 2000 | 67 | 2000 |
| Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II: do somatic symptoms compromise validity? AL Patterson, BJ Morasco, BE Fuller, DW Indest, JM Loftis, P Hauser General Hospital Psychiatry 33 (4), 354-362, 2011 | 65 | 2011 |
| Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review JA Nelligan, JM Loftis, AM Matthews, BL Zucker, AM Linke, P Hauser The Journal of clinical psychiatry 69 (5), 4171, 2008 | 64 | 2008 |
| Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study JM Loftis, AL Patterson, CJ Wilhelm, H McNett, BJ Morasco, M Huckans, ... Journal of Psychosomatic Research 74 (1), 57-63, 2013 | 63 | 2013 |
